Home | My NASDAQ | Tools | Mobile | Company List | ETFs | Pre-Market Quotes Real-Time Quotes After Hours Quotes
Home > Quotes > ALNY > Company News
ALNY
ALNY
$10.43
*
unch
negative
unch

*Data as of May 25, 2012   | Alnylam Pharmaceuticals, Inc. | Industry: Consumer Durables | HQ: Massachusetts, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 |  Sponsored

ALNY News Headlines

Share |


   


Alnylam Pharma, PBL Sign License Deal For Baulcombe & Hamilton RNAi Patent
5/23/2012 8:18:00 AM - RTT News

Alnylam To Present At Bank Of America Conference; Webcast At 12:20 PM ET
5/17/2012 11:21:00 AM - RTT News

Alnylam To Present At JMP Securities Research Conference; Webcast At 5:30 PM ET
5/15/2012 3:03:00 PM - RTT News

Alnylam Narrows Loss - Analyst Blog
5/4/2012 1:38:01 PM - Zacks.com

Alnylam Pharmaceuticals Q1 12 Earnings Conference Call At 4:30 PM ET
5/3/2012 3:03:00 PM - RTT News

Tekmira Says Its LNP Tech Enables Alnylam's Positive ALN-PCS Clinical Data
4/20/2012 11:36:00 AM - RTT News

Alnylam To Present At Biotech Industry Conference; Webcast At 10:00 AM ET
4/20/2012 9:01:00 AM - RTT News

Alnylam Pharma Reports Positive Phase I Trial Results Of ALN-PCS
4/20/2012 8:14:00 AM - RTT News

Alnylam To Present At Needham Healthcare Conference At 10:40 AM ET
4/4/2012 9:40:00 AM - RTT News

The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach - Press Releases
3/28/2012 9:24:38 AM - Zacks.com

Encouraging Data on Amgen Candidate - Analyst Blog
3/27/2012 12:22:16 PM - Zacks.com

Alnylam Begins Phase I Clinical Study Of ALN-TTR02
3/19/2012 12:29:00 PM - RTT News

What Alnylam Doesn't Want You To Know
3/16/2012 9:54:00 AM - Seeking Alpha

Alnylam Pharma To Presenta At Barclays Capital Conference; Webcast At 4:15 PM ET
3/13/2012 3:00:00 PM - RTT News

Good News For Alnylam: PBL Making Baulcombe Patent Widely Available
3/11/2012 11:18:00 AM - Seeking Alpha

Diabetes Market: Eli Lilly's Classic Pharma Vs. Sanofi Aventis' Modern Synergy
3/8/2012 6:24:00 PM - Seeking Alpha

Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts
3/7/2012 8:13:00 AM - Seeking Alpha

Tekmira Pharma Files Motion To Dismiss In Patent Infringement Suit
3/6/2012 12:02:00 PM - RTT News

Noteworthy Insider Buys And Sells In Healthcare On Wednesday To Friday
2/26/2012 4:10:00 AM - Seeking Alpha

11 Takeover/LBO Targets With Increasing Short Interest
2/22/2012 11:59:00 PM - Seeking Alpha

Illumina, Roche And Fairness
2/9/2012 5:37:00 PM - Seeking Alpha

Verastem: Killing Cancer At The Root
2/2/2012 6:55:00 AM - Seeking Alpha

Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach
1/30/2012 9:07:00 AM - Seeking Alpha

6 Biotech Stocks On Impressive Winning Streaks
1/23/2012 3:36:00 AM - Seeking Alpha

Why Prolor Biotech Is Rising And Other Attractive Prospects
1/20/2012 7:32:00 AM - Seeking Alpha